163 related articles for article (PubMed ID: 35284131)
21. A new model based on gamma-glutamyl transpeptidase to lymphocyte ratio and systemic immune-inflammation index can effectively predict the recurrence of hepatocellular carcinoma after liver transplantation.
Zhang W; Bi Y; Yang K; Xie Y; Li Z; Yu X; Zhang L; Jiang W
Front Oncol; 2023; 13():1178123. PubMed ID: 37152021
[TBL] [Abstract][Full Text] [Related]
22. The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy.
Su CW; Chiou YW; Tsai YH; Teng RD; Chau GY; Lei HJ; Hung HH; Huo TI; Wu JC
PLoS One; 2013; 8(6):e66457. PubMed ID: 23805222
[TBL] [Abstract][Full Text] [Related]
23. A new plasma biomarker enhance the clinical prediction of postoperative acute kidney injury in patients with hepatocellular carcinoma.
Zhou X; Wang L; Wang G; Cheng X; Hu S; Ke W; Li M; Zhang Y; Song Z; Zheng Q
Clin Chim Acta; 2017 Dec; 475():128-136. PubMed ID: 29031454
[TBL] [Abstract][Full Text] [Related]
24. Positive HBcAb is associated with higher risk of early recurrence and poorer survival after curative resection of HBV-related HCC.
Li T; Wang SK; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Fan J
Liver Int; 2016 Feb; 36(2):284-92. PubMed ID: 26104132
[TBL] [Abstract][Full Text] [Related]
25. Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load.
Sohn W; Paik YH; Cho JY; Ahn JM; Choi GS; Kim JM; Kwon CH; Joh JW; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
J Viral Hepat; 2015 Jun; 22(6):539-50. PubMed ID: 25377516
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Nomogram for Sorafenib Benefit in Hepatitis B Virus-Related Hepatocellular Carcinoma After Partial Hepatectomy.
Dong W; Yan K; Yu H; Huo L; Xian Z; Zhao Y; Li J; Zhang Y; Cao Z; Fu Y; Cong W; Dong H
Front Oncol; 2020; 10():605057. PubMed ID: 33643907
[TBL] [Abstract][Full Text] [Related]
27. Gamma glutamyl transpeptidase as a prognostic biomarker in hepatocellular cancer patients especially with >5 cm tumors, treated by liver transplantation.
Ince V; Carr BI; Bag HG; Koc C; Usta S; Ersan V; Baskiran A; Sahin TT; Yilmaz S
Int J Biol Markers; 2020 Jun; 35(2):91-95. PubMed ID: 32436751
[TBL] [Abstract][Full Text] [Related]
28. Level of hepatitis B surface antigen might serve as a new marker to predict hepatocellular carcinoma recurrence following curative resection in patients with low viral load.
Zhou HB; Li QM; Zhong ZR; Hu JY; Jiang XL; Wang H; Wang H; Yang B; Hu HP
Am J Cancer Res; 2015; 5(2):756-71. PubMed ID: 25973313
[TBL] [Abstract][Full Text] [Related]
29. Nomogram for individualized prediction of recurrence after postoperative adjuvant TACE for hepatitis B virus-related hepatocellular carcinoma.
Jiang J; Hu H; Liu R; Wang JH; Long XR; Fan J; Yan ZP
Medicine (Baltimore); 2017 Aug; 96(32):e7390. PubMed ID: 28796032
[TBL] [Abstract][Full Text] [Related]
30. Change in γ-glutamyl transpeptidase activity as a useful tool in identifying a group of patients with elevated risk of hepatocellular carcinoma development after DAA treatment of chronic hepatitis C.
Orzechowska D; Klimowicz K; Stępień A; Mikuła T; Sapuła M; Wiercińska-Drapało A
Clin Exp Hepatol; 2021 Mar; 7(1):93-100. PubMed ID: 34027121
[TBL] [Abstract][Full Text] [Related]
31. Nomogram to Predict Survival of Patients With Recurrence of Hepatocellular Carcinoma After Surgery.
He W; Peng B; Tang Y; Yang J; Zheng Y; Qiu J; Zou R; Shen J; Li B; Yuan Y
Clin Gastroenterol Hepatol; 2018 May; 16(5):756-764.e10. PubMed ID: 29246702
[TBL] [Abstract][Full Text] [Related]
32. Simple models based on gamma-glutamyl transpeptidase and platelets for predicting survival in hepatitis B-associated hepatocellular carcinoma.
Pang Q; Bi JB; Wang ZX; Xu XS; Qu K; Miao RC; Chen W; Zhou YY; Liu C
Onco Targets Ther; 2016; 9():2099-109. PubMed ID: 27110127
[TBL] [Abstract][Full Text] [Related]
33. High serum gamma-glutamyl transpeptidase concentration associates with poor postoperative prognosis of patients with hepatitis B virus-associated intrahepatic cholangiocarcinoma.
Zhang B; Liu S; Zhou B; Guo L; Li H; Yan J; Zhang W; Yu M; Chen Z; Xu Y; Xiao Y; Ye Q
Ann Transl Med; 2021 Jan; 9(1):17. PubMed ID: 33553310
[TBL] [Abstract][Full Text] [Related]
34. Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients.
Lin YJ; Lee MH; Yang HI; Jen CL; You SL; Wang LY; Lu SN; Liu J; Chen CJ
PLoS One; 2013; 8(4):e61448. PubMed ID: 23613855
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of a nomogram to predict the recurrence of hepatocellular carcinoma patients with dynamic changes in AFP undergoing locoregional treatments.
Sun Y; Xiong Y; Wang Q; Qiao W; Zhang H; Zhang Y
Front Oncol; 2023; 13():1206345. PubMed ID: 37700838
[TBL] [Abstract][Full Text] [Related]
36. A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma.
Peng J; Zhang J; Zhang Q; Xu Y; Zhou J; Liu L
Diagn Interv Radiol; 2018; 24(3):121-127. PubMed ID: 29770763
[TBL] [Abstract][Full Text] [Related]
37. Prognostic nomogram for post-surgical treatment with adjuvant TACE in hepatitis B virus-related hepatocellular carcinoma.
Hu H; Han XK; Long XR; Fan J; Yan ZP; Wang JH; Liu R
Oncotarget; 2016 Sep; 7(36):58302-58314. PubMed ID: 27506942
[TBL] [Abstract][Full Text] [Related]
38. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.
Sohn W; Paik YH; Kim JM; Kwon CH; Joh JW; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Ann Surg Oncol; 2014 Jul; 21(7):2429-35. PubMed ID: 24619495
[TBL] [Abstract][Full Text] [Related]
39. Development and Validation of a Prognostic Nomogram in AFP-negative hepatocellular carcinoma.
Wang X; Mao M; He Z; Zhang L; Li H; Lin J; He Y; Dai S; Hu W; Liu W
Int J Biol Sci; 2019; 15(1):221-228. PubMed ID: 30662361
[TBL] [Abstract][Full Text] [Related]
40. Validated nomogram for the prediction of disease-free survival after hepatectomy for hepatocellular carcinoma within the Milan criteria: individualizing a surveillance strategy.
Ma KW; She WH; Cheung TT; Chan ACY; Dai WC; Fung JYY; Lo CM; Chok KSH
Surg Today; 2019 Jun; 49(6):521-528. PubMed ID: 30637484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
